Global Pharyngitis Therapeutics Market Analysis By Drug Class , Mode of Delivery, Dynamics, Trends, Growth & Forecast 2023-2032

 

Global Pharyngitis Therapeutics Market

Global pharyngitis treatment market in the forecast period 2023-2032. The expected CAGR of pharyngitis treatment market is tend to be around 4.9% in the mentioned forecast period. The market was valued at USD 2.20 billion in 2022, and it would grow up to USD 3.23 billion by 2032.

Pharyngitis, also known as sore throat, is an inflammation of the pharynx, which is the part of the throat that lies between the mouth and the larynx. Pharyngitis is a common condition, which can be caused by viral or bacterial infections. The pharyngitis therapeutics market is driven by the high incidence of pharyngitis worldwide and the increasing demand for effective treatments for the condition.

The market for pharyngitis therapeutics is segmented based on the type of treatment, including antibiotics, analgesics, anti-inflammatory drugs, and others. Antibiotics are the most commonly prescribed treatment for bacterial pharyngitis, while analgesics and anti-inflammatory drugs are used to provide relief from pain and inflammation associated with pharyngitis.

The market is also segmented based on distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is expected to dominate the market due to the high preference for hospital treatment for pharyngitis.

 

Get a Free Sample Copy of a Research Report:  https://analyticsmarketresearch.com/sample-request/pharyngitis-therapeutics-market/76825/

 

COVID Impact
The COVID-19 pandemic has had a significant impact on the pharyngitis therapeutics market. While pharyngitis is not a direct effect of COVID-19, the pandemic has led to changes in healthcare systems and patient behavior that have affected the market.

One of the major impacts of the pandemic on the pharyngitis therapeutics market is the disruption of supply chains. Many countries have imposed restrictions on the movement of goods and people, which has led to delays in the production and distribution of pharyngitis drugs. This has resulted in shortages of certain drugs and increased prices for others.

Another impact of the pandemic on the market is the shift towards telemedicine and remote consultations. With social distancing measures in place, many patients have been reluctant to visit healthcare facilities in person. This has led to an increase in the use of telemedicine and remote consultations for the diagnosis and treatment of pharyngitis. This trend is expected to continue even after the pandemic subsides, which could affect the demand for certain types of pharyngitis therapeutics.

Furthermore, the pandemic has also led to a greater focus on prevention, which could reduce the demand for pharyngitis therapeutics. Public health campaigns promoting hand washing, wearing masks, and social distancing may help to reduce the spread of infectious diseases, including pharyngitis.

Overall, the COVID-19 pandemic has had a significant impact on the pharyngitis therapeutics market. While some factors have led to increased demand for certain drugs, other factors have disrupted supply chains and changed patient behavior, which could affect the market in the long term.

Global Pharyngitis Treatment Market Dynamics

Drivers

Increased Incidence of Pharyngitis

In 2020, more than 2.8 million people were reported to suffer from pharyngitis, with 1.1 million children under the age of 16. Pharyngitis is most common in kids under the age of 5 years. Adults also witness this condition but it develops slowly in them. Pharyngitis occurrences are quite high over the world, mainly in nations when antibiotics are extensively prescribed.

Growing Awareness about Viral Infections

The increasing awareness about several viral infections led to the growth of the market. Flu, AIDS, and Ebola virus public awareness campaigns are also a vital component in raising public knowledge and, consequently, affecting segment growth. The World Health Organization (WHO) advises countries to maintain routine viral disease surveillance, specimens from surveillance sites for viral diseases and launches various campaigns for the diseases.

Opportunities

Increase in GAS pharyngitis

As per the recent research, about 70% of streptococcal infections of the respiratory tract are non-symptomatic, and these infections can cause serious non-suppurative reaction. Even though acute pharyngitis is one of the most prevalent diseases among school-going children, GAS pharyngitis is uncommon. GAS pharyngitis and non-streptococcal pharyngitis have almost similar clinical appearances, making it difficult for physicians to differentiate between them without laboratory analysis.

Increasing Demand of Antiviral Drugs

Pharyngitis treatment market for antiviral drugs is estimated to dominate the market by the end of 2030 and the segment is expected to witness exponential growth rate during the forecast period 2022-2030. It has been witnessed that Amoxicillin and penicillin are the most commonly prescribed antibiotics for strep throat and are likely to uphold the market growth.

Restraints/Challenges

Lack of skilled professionals

The lack of qualified healthcare professional unable to perform the treatments could reduce the growth of the pharyngitis treatment market during the forecast period.

Side-Effects of pharyngitis treatment

The adverse side-effects associated with the treatment process hinder the market growth. Effects such as infections, itching and also some drugs can lead to severe reactions

This pharyngitis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.

Market Segmentation:

Based on the type of treatment, the market can be segmented as follows:

1. Antibiotics: The antibiotics segment is expected to dominate the market due to the high prevalence of bacterial pharyngitis and the effectiveness of antibiotics in treating the condition.

2. Analgesics: The analgesics segment is expected to grow at a significant rate due to the high demand for pain relief medications for pharyngitis.

3. Anti-inflammatory drugs: The anti-inflammatory drugs segment is expected to grow at a significant rate due to the high incidence of inflammation associated with pharyngitis.

4. Others: Other treatment options for pharyngitis include antivirals, steroids, and immune modulators.

Based on distribution channels, the market can be segmented as follows:

1. Hospital pharmacies: Hospital pharmacies are expected to dominate the market due to the high preference for hospital treatment for pharyngitis.

2. Retail pharmacies: The retail pharmacies segment is expected to grow at a significant rate due to the increasing availability of over-the-counter medications for pharyngitis.

3. Online pharmacies: The online pharmacies segment is expected to grow at a significant rate due to the increasing use of e-commerce platforms for purchasing medications.

Based on geography, the market can be segmented into:

1. North America: The North American market is expected to dominate the market due to the high prevalence of pharyngitis in the region and the increasing demand for effective treatments.

2. Europe: The European market is expected to grow at a significant rate due to the increasing awareness of pharyngitis and the growing demand for better healthcare infrastructure.

3. Asia Pacific: The Asia Pacific market is expected to grow at the highest CAGR during the forecast period due to the increasing incidence of pharyngitis in the region and the growing demand for better healthcare infrastructure.

4. Latin America: The Latin American market is expected to grow at a significant rate due to the increasing incidence of pharyngitis in the region and the growing demand for better healthcare infrastructure.

5. Middle East and Africa: The Middle East and Africa market is expected to grow at a significant rate due to the increasing awareness of pharyngitis and the growing demand for better healthcare infrastructure.

 

Key Player:

Some of the major players in the market include:
1. Pfizer Inc.
2. Merck & Co., Inc.
3. Novartis AG
4. Teva Pharmaceutical Industries Ltd.
5. GlaxoSmithKline plc
6. Sanofi S.A.
7. AstraZeneca plc
8. Bayer AG
9. Johnson & Johnson
10. Bristol-Myers Squibb Company

 

Regional Analysis:

The pharyngitis treatment market is analyzed and market size insights and trends are provided by drug class, mode of delivery, distribution channel and end-user as referenced above.

The major countries covered in the pharyngitis treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the presence of key manufacturers of the product is high and, increasing research and development activities.

Asia-Pacific dominates the market due to increased new research and developments on Pharyngitis Treatment market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

 

Get the Detail Information: - https://analyticsmarketresearch.com/reports/pharyngitis-therapeutics-market/76825/

 

About US:
Analytics Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep -rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. Analytics Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

 

Contact US:
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005
Phone: +1(650)-666-4592
Email: sales@analyticsmarketresearch.com
Web: https://analyticsmarketresearch.com/